BC Partners has carved out Netherlands-based Synthon International, a pharmaceutical company specialising in the development and distribution of complex generics, from its parent company Synthon Holding.
Fund has raised €1bn of its €1.1bn target and plans to hold a final close in Q1 2020
GP will take a minority stake, with the Reisenthel family as majority shareholders
Horizon expects to merge the two IT services providers to create a business with 300 developers
EQT deploys capital from its EQT VIII fund, which hit its €10.75bn hard-cap in 2018